Mia's Feed
Medical News & Research

Advancing Monitoring and Intervention Strategies for Commercial Determinants of Health

Advancing Monitoring and Intervention Strategies for Commercial Determinants of Health

Share this article

Exploring how regulations and transparency in corporate practices can improve public health by reducing harmful influences, promoting better policy and corporate accountability.

2 min read

Recent research highlights the importance of systematically tracking and addressing the influence of corporate practices on public health. A study conducted by scholars from Yale University and the City University of New York emphasizes that implementing regulations requiring corporations to disclose harmful activities—such as marketing tactics, toxic emissions, and workplace hazards—can significantly enhance public health protections. Such transparency enables governments to better regulate harmful corporate behaviors that contribute to chronic diseases, mental health issues, global warming, and pollution.

The researchers identify two critical steps for progress: developing robust systems to measure corporate practices impacting health and formulating effective policies to mitigate these effects. A major challenge remains the scarcity of accessible, high-quality data on corporate actions, as existing efforts often rely on voluntary or incomplete disclosures. One promising approach examined is corporate nonfinancial reporting, including environmental, social, and governance disclosures. However, these reports face issues like inconsistency, superficiality, or greenwashing, which can undermine their reliability.

To overcome these hurdles, the study draws lessons from global initiatives and proposes five key principles for policy development: focusing on high-impact actions; addressing harmful practices across multiple levels; encouraging cooperation among governments, civil society, and international bodies; anticipating unintended consequences; and effectively communicating the urgency of addressing commercial influences on health.

By adhering to these principles, policymakers and corporations can reduce the adverse effects of unethical business practices. This effort can contribute substantially to lowering the prevalence of chronic and infectious diseases, mental health problems, environmental degradation, and pollution, ultimately fostering a healthier society.

More information on this research can be found in the article "Toward Monitoring and Addressing the Commercial Determinants of Health: Where Can We Go From Here?" published in The Milbank Quarterly (2025).

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Gene Editing Technique Stabilizes and Disrupts Huntington's Disease Mutations in Mice

A groundbreaking gene editing approach has successfully stabilized and disrupted harmful DNA repeats responsible for Huntington's disease in mice, paving the way for future therapies.

Discontinuing Blood Thinner Therapy After Successful Atrial Fibrillation Treatment May Reduce Risks

New research indicates that stopping anticoagulation therapy after successful atrial fibrillation ablation may lower risks of stroke and bleeding, offering potential changes to long-term treatment strategies.

Atrial Fibrillation Treatment: Catheter Ablation Reduces Long-Term Risk of Stroke and Heart Failure

Catheter ablation for atrial fibrillation significantly lowers the long-term risk of stroke, death, and heart failure hospitalization after the initial 30 days, offering a promising intervention for better cardiovascular health.

Long COVID Continues to Impose Significant Financial and Medical Challenges, New Study Reveals

New study reveals that long COVID causes prolonged medical and financial hardships for patients, with vaccination improving outcomes. Learn more about the societal impact of this persistent condition.